Dupont US Holding, LLC
30 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded as renamed to Iff US Holding, LLC (2023)
42
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 23, 2026The maintenance fee for Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications (US 9,062,312) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due Jan 21, 2027The maintenance fee for Method for the enhanced recovery of catmint oil (US 9,085,747) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Feb 25, 2027The maintenance fee for Cysteine cross-linked structural peptides (US 9,115,182) comes due Feb 25, 2027. Unpaid by Aug 25, 2027, it lapses early.
- 2 fees due May 3 to 17, 2027 · next May 3
Recent changes
- 1 term has ended since Aug 24, 2026
- Nov 16 US 8,048,653 Microbial oils produced in transformed host cells comprising delta-9 elongases · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,026,089 | Mutant Δ8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids In force · USPTO record | In force | USPTO record | |
| US 7,807,425 | Production of peracids using an enzyme having perhydrolysis activity In force · USPTO record | In force | USPTO record | |
| US 7,829,315 | Production of peracids using an enzyme having perhydrolysis activity In force · USPTO record | In force | USPTO record | |
| US 7,951,567 | Production of peracids using an enzyme having perhydrolysis activity In force · USPTO record | In force | USPTO record | |
| US 8,063,008 | Enzymatic production of peracids using perhydrolytic enzymes In force · USPTO record | In force | USPTO record | |
| US 8,329,441 | Production of peracids using an enzyme having perhydrolysis activity In force · USPTO record | In force | USPTO record | |
| US 7,572,612 | Method of production of para-hydroxycinnamic acid using a thermostable TAL enzyme In force · USPTO record | In force | USPTO record | |
| US 8,518,675 | Production of peracids using an enzyme having perhydrolysis activity In force · USPTO record | In force | USPTO record | |
| US 7,700,328 | Method for producing an L-tyrosine over-producing bacterial strain In force · USPTO record | In force | USPTO record | |
| US 7,550,420 | Enzymatic production of peracids using perhydrolytic enzymes In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 66: 30 patents in force now held by others · 96 lapsed for an unpaid fee · 43 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 abandoned · 1 no status recorded